Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Filamon LTD
Trogenix ltd
Eli Lilly and Company
Neonc Technologies, Inc.
M.D. Anderson Cancer Center
Lantern Pharma Inc.
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
Essen Biotech
Essen Biotech